was read the article
array:24 [ "pii" => "S2341287915001775" "issn" => "23412879" "doi" => "10.1016/j.anpede.2015.09.014" "estado" => "S300" "fechaPublicacion" => "2015-11-01" "aid" => "1828" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2015;83:354.e1-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2810 "formatos" => array:3 [ "EPUB" => 141 "HTML" => 2155 "PDF" => 514 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403315000727" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2015.02.012" "estado" => "S300" "fechaPublicacion" => "2015-11-01" "aid" => "1828" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2015;83:354.e1-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 15271 "formatos" => array:3 [ "EPUB" => 169 "HTML" => 12694 "PDF" => 2408 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA</span>" "titulo" => "Recomendaciones para la asistencia respiratoria en el recién nacido (<span class="elsevierStyleSmallCaps">iii</span>). Surfactante y óxido nítrico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354.e1" "paginaFinal" => "354.e6" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Recommendations for respiratory support in the newborn (<span class="elsevierStyleSmallCaps">iii</span>). Surfactant and nitric oxide" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Castillo Salinas, D. Elorza Fernández, A. Gutiérrez Laso, J. Moreno Hernando, G. Bustos Lozano, M. Gresa Muñoz, J. López de Heredia Goya, M. Aguar Carrascosa, X. Miracle Echegoyen, J.R. Fernández Lorenzo, M.M. Serrano, A. Concheiro Guisan, C. Carrasco Carrasco, J.J. Comuñas Gómez, M.T. Moral Pumarega, A.M. Sánchez Torres, M.L. Franco" "autores" => array:18 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Castillo Salinas" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Elorza Fernández" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Gutiérrez Laso" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Moreno Hernando" ] 4 => array:2 [ "nombre" => "G." "apellidos" => "Bustos Lozano" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Gresa Muñoz" ] 6 => array:2 [ "nombre" => "J." "apellidos" => "López de Heredia Goya" ] 7 => array:2 [ "nombre" => "M." "apellidos" => "Aguar Carrascosa" ] 8 => array:2 [ "nombre" => "X." "apellidos" => "Miracle Echegoyen" ] 9 => array:2 [ "nombre" => "J.R." "apellidos" => "Fernández Lorenzo" ] 10 => array:2 [ "nombre" => "M.M." "apellidos" => "Serrano" ] 11 => array:2 [ "nombre" => "A." "apellidos" => "Concheiro Guisan" ] 12 => array:2 [ "nombre" => "C." "apellidos" => "Carrasco Carrasco" ] 13 => array:2 [ "nombre" => "J.J." "apellidos" => "Comuñas Gómez" ] 14 => array:2 [ "nombre" => "M.T." "apellidos" => "Moral Pumarega" ] 15 => array:2 [ "nombre" => "A.M." "apellidos" => "Sánchez Torres" ] 16 => array:2 [ "nombre" => "M.L." "apellidos" => "Franco" ] 17 => array:1 [ "colaborador" => "en representación del Grupo Respiratorio y Surfactante de la Sociedad Española de Neonatología" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287915001775" "doi" => "10.1016/j.anpede.2015.09.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287915001775?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403315000727?idApp=UINPBA00005H" "url" => "/16954033/0000008300000005/v1_201510300037/S1695403315000727/v1_201510300037/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341287915001726" "issn" => "23412879" "doi" => "10.1016/j.anpede.2015.09.009" "estado" => "S300" "fechaPublicacion" => "2015-11-01" "aid" => "1848" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2015;83:355.e1-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3050 "formatos" => array:3 [ "EPUB" => 140 "HTML" => 2351 "PDF" => 559 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>" "titulo" => "The introduction of gluten into the infant diet. Expert group recommendations" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "355.e1" "paginaFinal" => "355.e7" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La introducción del gluten en la dieta del lactante. Recomendaciones de un grupo de expertos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ribes Koninckx, J. Dalmau Serra, J.M. Moreno Villares, J.J. Diaz Martín, G. Castillejo de Villasante, I. Polanco Allue" "autores" => array:6 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ribes Koninckx" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Dalmau Serra" ] 2 => array:2 [ "nombre" => "J.M." "apellidos" => "Moreno Villares" ] 3 => array:2 [ "nombre" => "J.J." "apellidos" => "Diaz Martín" ] 4 => array:2 [ "nombre" => "G." "apellidos" => "Castillejo de Villasante" ] 5 => array:2 [ "nombre" => "I." "apellidos" => "Polanco Allue" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403315001071" "doi" => "10.1016/j.anpedi.2015.03.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403315001071?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287915001726?idApp=UINPBA00005H" "url" => "/23412879/0000008300000005/v1_201512040119/S2341287915001726/v1_201512040119/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S234128791500201X" "issn" => "23412879" "doi" => "10.1016/j.anpede.2015.10.002" "estado" => "S300" "fechaPublicacion" => "2015-11-01" "aid" => "1829" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2015;83:353.e1-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5155 "formatos" => array:3 [ "EPUB" => 148 "HTML" => 4346 "PDF" => 661 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Spanish Association of Paediatrics</span>" "titulo" => "Use of sugars and sweeteners in children's diets. Recommendations of the Nutrition Committee of the Spanish Association of Paediatrics" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "353.e1" "paginaFinal" => "353.e7" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Uso de azúcares y edulcorantes en la alimentación del niño. Recomendaciones del Comité de Nutrición de la Asociación Española de Pediatría" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Gil-Campos, M.A. San José González, J.J. Díaz Martín" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Gil-Campos" ] 1 => array:2 [ "nombre" => "M.A." "apellidos" => "San José González" ] 2 => array:2 [ "nombre" => "J.J." "apellidos" => "Díaz Martín" ] 3 => array:1 [ "colaborador" => "Comité de Nutrición de la Asociación Española de Pediatría" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403315000739" "doi" => "10.1016/j.anpedi.2015.02.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403315000739?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128791500201X?idApp=UINPBA00005H" "url" => "/23412879/0000008300000005/v1_201512040119/S234128791500201X/v1_201512040119/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Spanish Association of Paediatrics</span>" "titulo" => "Recommendations for respiratory support in the newborn (III). Surfactant and nitric oxide" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354.e1" "paginaFinal" => "354.e6" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "F. Castillo Salinas, D. Elorza Fernández, A. Gutiérrez Laso, J. Moreno Hernando, G. Bustos Lozano, M. Gresa Muñoz, J. López de Heredia Goya, M. Aguar Carrascosa, X. Miracle Echegoyen, J.R. Fernández Lorenzo, M.M. Serrano, A. Concheiro Guisan, C. Carrasco Carrasco, J.J. Comuñas Gómez, M.T. Moral Pumarega, A.M. Sánchez Torres, M.L. Franco" "autores" => array:18 [ 0 => array:4 [ "nombre" => "F." "apellidos" => "Castillo Salinas" "email" => array:1 [ 0 => "felixpapa@yahoo.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "D." "apellidos" => "Elorza Fernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "A." "apellidos" => "Gutiérrez Laso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "J." "apellidos" => "Moreno Hernando" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "G." "apellidos" => "Bustos Lozano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "M." "apellidos" => "Gresa Muñoz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "J." "apellidos" => "López de Heredia Goya" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "M." "apellidos" => "Aguar Carrascosa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 8 => array:3 [ "nombre" => "X." "apellidos" => "Miracle Echegoyen" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 9 => array:3 [ "nombre" => "J.R." "apellidos" => "Fernández Lorenzo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 10 => array:3 [ "nombre" => "M.M." "apellidos" => "Serrano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">j</span>" "identificador" => "aff0050" ] ] ] 11 => array:3 [ "nombre" => "A." "apellidos" => "Concheiro Guisan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 12 => array:3 [ "nombre" => "C." "apellidos" => "Carrasco Carrasco" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 13 => array:3 [ "nombre" => "J.J." "apellidos" => "Comuñas Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 14 => array:3 [ "nombre" => "M.T." "apellidos" => "Moral Pumarega" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 15 => array:3 [ "nombre" => "A.M." "apellidos" => "Sánchez Torres" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 16 => array:3 [ "nombre" => "M.L." "apellidos" => "Franco" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">k</span>" "identificador" => "aff0055" ] ] ] 17 => array:1 [ "colaborador" => "on behalf of Grupo Respiratorio y Surfactante de la Sociedad Española de Neonatología" ] ] "afiliaciones" => array:11 [ 0 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario Vall d’Hebron, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario La Paz, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario La Fe, Valencia, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario Sant Joan de Déu, Barcelona, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Materno-Insular Las Palmas, Las Palmas, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital de Cruces, Barakaldo, Vizcaya, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Clínic-Maternidad, Barcelona, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servicio de Neonatología, Complejo Universitario de Vigo, Vigo, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Materno-Infantil Carlos Haya, Málaga, Spain" "etiqueta" => "j" "identificador" => "aff0050" ] 10 => array:3 [ "entidad" => "Servicio de Neonatología, Hospital Universitario Gregorio Marañón, Madrid, Spain" "etiqueta" => "k" "identificador" => "aff0055" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Recomendaciones para la asistencia respiratoria en el recién nacido (<span class="elsevierStyleSmallCaps">iii</span>). Surfactante y óxido nítrico" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Surfactant</span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">General concepts and types of surfactants</span><p id="par0005" class="elsevierStylePara elsevierViewall">Pulmonary surfactant is a surface-active substance produced by type II pneumocytes and essentially formed by a lipoprotein complex. Phosphatidylcholine accounts for 70% of its lipid component, while four different types of surfactant proteins have been described in the literature, the most important of which are SP-B and SP-D.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">1</span></a> The main function of surfactant is to reduce surface tension at the alveolar air–liquid interface, preventing the lungs from collapsing on expiration.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Starting at 22 weeks of gestation, during the canalicular period of foetal lung development, lamellar bodies loaded with surfactant can be found inside type II pneumocytes, but it is not until the end of this period that pulmonary development and the surfactant system are fully effective in guaranteeing an adequate gas exchange.</p><p id="par0015" class="elsevierStylePara elsevierViewall">For this reason, children born before 34 weeks (sometimes up to 36) of gestation may have a deficiency of pulmonary surfactant, which is the cause of respiratory distress syndrome (RSD). This deficiency leads to alveolar collapse, producing respiratory distress, hypoxaemia and hypercapnia.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Surfactant therapy has revolutionised the care of these patients since its introduction in 1980. Combined with the use of corticosteroids for accelerating the antenatal maturation of the lungs and advances in respiratory support, it has contributed to an increase in the survival of preterm newborns. At present, surfactant administration is considered a safe and effective treatment, both as prophylaxis and rescue therapy, in newborns at high risk of developing RSD.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Many aspects of its use have been investigated in multiple multicentre controlled studies that have been subsequently analysed in systematic reviews.<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">2,3</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">In recent years, different commercial preparations have been developed that vary in composition and clinical outcomes.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">4</span></a> The most widely used are:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0035" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Synthetic surfactants:</span> they were the first type to be marketed. Colfosceril (Exosurf<span class="elsevierStyleSup">®</span>), consisting solely of dipalmitoylphosphatidylcholine, is no longer available. Later on, lucinactant (Surfaxin<span class="elsevierStyleSup">®</span>), whose composition includes a peptide that mimics the action of SP-B, was introduced in the market.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0040" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Natural surfactants:</span> they are basically classified into those derived from bovine (beractant, Survanta<span class="elsevierStyleSup">®</span>) or porcine (poractant, Curosurf<span class="elsevierStyleSup">®</span>) ground lung extracts and those derived from bovine bronchoalveolar lavage (calfactant, Infasurf<span class="elsevierStyleSup">®</span>).</p></li></ul></p><p id="par0045" class="elsevierStylePara elsevierViewall">Treatment with natural surfactants has certain advantages over first-generation synthetic surfactants. Natural surfactants have shown a faster onset of action and a greater reduction in the number of fatalities and pneumothorax cases when compared with the first generation of synthetic surfactants.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">5</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Lucinactant has been compared with natural surfactants. However, these studies were criticised due to early trial closures and inadequate sample sizes.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">6–8</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Therefore, natural surfactants are currently the first-line treatment for RDS in preterm newborns (PTNBRDS), and no other type of surfactant is available in Europe. Thus, the decision we may face as neonatologists is which natural surfactant to use.</p><p id="par0060" class="elsevierStylePara elsevierViewall">All the natural surfactant preparations differ slightly in their phospholipid and protein concentrations, as well as in the recommended dose for each patient measured in units of volume or milligrams per kilogram of body weight. Many randomised controlled trials have been conducted to try to find differences in clinical outcomes between the various preparations.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">9,10</span></a> Some of these studies found faster improvements in oxygenation, reduced need for retreatment and lower mortality when patients were treated with poractant alfa compared to other natural surfactants such as beractant. The pharmacological and clinical data of these studies indicate that a dose of 200<span class="elsevierStyleHsp" style=""></span>mg/kg results in a higher half life and better outcomes in the acute patient, and this is the recommended dose.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">11</span></a> However, the relatively small number of newborns that has been studied may not suffice to establish a generalised recommendation.</p><p id="par0065" class="elsevierStylePara elsevierViewall">The American Academy of Pediatrics has concluded that there is no clear evidence that significant differences exist in the clinical outcomes of patients between the different available natural surfactant preparations.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">2</span></a></p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Indications</span><p id="par0070" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0075" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">PTNBRDS:</span> is the main therapeutic indication for surfactant, which has been the standard treatment for more than two decades. Its use in this pathology is unquestionable, as it has been proven to reduce the risk of pneumothorax and interstitial lung disease, the need for mechanical ventilation, and neonatal mortality.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">3,12–15</span></a></p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0080" class="elsevierStylePara elsevierViewall">Exogenous surfactant has been used to treat other respiratory diseases that lead to the transient inactivation, insufficiency or dysfunction of pulmonary surfactant. There are few controlled studies on this subject to support generalised recommendations for surfactant indication and therapeutic strategies in these patients.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">-</span><p id="par0085" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Meconium aspiration syndrome (MAS):</span> improved oxygenation and a reduced need for ECMO upon administration of 4 doses of surfactant at 6<span class="elsevierStyleHsp" style=""></span>h intervals has been reported.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">16</span></a> Thus, the use of surfactant could be recommended in patients with more severe presentations of MAS and oxygenation indices greater than 15, and should start as soon as possible (ideally within six hours of birth).<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">17</span></a> Another possibility is bronchoalveolar lavage with surfactant, with demonstrated advantages over lavage with saline or placebo, although the optimal suction method and amount of surfactant have yet to be defined clearly.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">18</span></a></p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">-</span><p id="par0090" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pulmonary haemorrhage:</span> there are no randomised controlled clinical trials for this indication. An observational study found promising results, with a reduced need for respiratory support without additional complications.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">19</span></a></p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">-</span><p id="par0095" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pneumonia and sepsis:</span> data from experimental models and studies on newborns suggest that alterations in alveolar surface tension develop in the context of inflammation due to infection,<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">20</span></a> especially by <span class="elsevierStyleItalic">Pseudomonas</span>, syncytial respiratory virus and group B streptococcus. Lotze et al. conducted a clinical trial on full-term newborns with respiratory failure and found that in the subgroup of patients diagnosed with sepsis or pneumonia, surfactant therapy significantly improved oxygenation and reduced the need for ECMO.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">21</span></a></p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">-</span><p id="par0100" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Other indications:</span> in recent years, surfactant therapy has also been used for respiratory distress of other aetiologies, such as diaphragmatic hernia and pulmonary hypertension.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">4</span></a></p></li></ul></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Administration and dosage</span><p id="par0105" class="elsevierStylePara elsevierViewall">Surfactant must be delivered directly to the inside of the lung. Its administration can be performed by invasive and noninvasive means.<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">-</span><p id="par0110" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Invasive administration:</span> requires the placement of an endotracheal tube for surfactant instillation. Current recommendations call for the early use of CPAP from birth and administration of surfactant as required, followed by extubation at the earliest opportunity, the foundation of the INSURE method: intubate-surfactant-rapidly extubate to CPAP.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">22</span></a> This approach has been shown to reduce the need for mechanical ventilation, but the debate continues, as the positive effects of prophylactic surfactant administration could be compromised by the short period of CPAP required by the INSURE method.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">-</span><p id="par0115" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Noninvasive administration:</span> consists in the administration of surfactant without intubation while the patient breathes spontaneously.</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">-</span><p id="par0120" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Nebuliser administration:</span> this alternative requires further research and discussion, and technical problems in nebuliser devices need to be resolved.<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">23</span></a></p></li><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">-</span><p id="par0125" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Administration without intubation:</span> consists in the administration of surfactant by means of a thin endotracheal tube or rigid catheter in spontaneously breathing patients while on noninvasive ventilatory support.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">24</span></a> It requires laryngoscopy for tube placement and may cause damage, especially in active preterm newborns.</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">-</span><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pharyngeal administration:</span> in recent years, alternative conduits have been investigated, such as oropharyngeal delivery or administration by means of a laryngeal mask airway.<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">25</span></a></p></li></ul></p><p id="par0135" class="elsevierStylePara elsevierViewall">Surfactant dosing depends on the commercial preparation due to differences in the amount of lipoproteins (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The European consensus guidelines for the management of neonatal RDS propose administration of poractant alfa in doses of 200<span class="elsevierStyleHsp" style=""></span>mg/kg, associated to better outcomes compared to 100<span class="elsevierStyleHsp" style=""></span>mg/kg doses of the same product or of beractant.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">26</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0140" class="elsevierStylePara elsevierViewall">The systematic review by Soll and Eren published in 2009 noted a reduction in the need for ventilatory support and in the incidence of pneumothorax, and a decreasing trend in mortality when multiple doses were used for the treatment of refractory respiratory insufficiency.<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">27</span></a> In the published studies, the administration regimen consisted of up to three doses, delivered at 12-h intervals while the patient continued to need oxygen therapy. However, it is not clear what the best retreatment schedule is. Natural surfactant manufacturers recommend different intervals, and different guidelines recommend different strategies. The European guidelines are not very specific and simply recommend a flexible course of treatment based on the need for mechanical ventilation and oxygen therapy.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">26</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">Some factors that may influence the retreatment schedule are the dose that was initially administered (200<span class="elsevierStyleHsp" style=""></span>mg/kg) and the presence of complicated RDS (infection, haemodynamic instability, perinatal morbidity).</p><p id="par0150" class="elsevierStylePara elsevierViewall">All surfactants must be stored refrigerated at 2–8<span class="elsevierStyleHsp" style=""></span>°C and must be brought to room temperature before administration.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Methods of administration</span><p id="par0155" class="elsevierStylePara elsevierViewall">Since the distribution of surfactant in the lungs depends mostly on gravity, it is recommended that the patient be kept in the horizontal supine position, with the head centred in the midline, and that surfactant be delivered by slow bolus infusion (over approximately 1<span class="elsevierStyleHsp" style=""></span>min).<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">28</span></a></p><p id="par0160" class="elsevierStylePara elsevierViewall">While different devices can be used in intubated patients, the use of double-lumen endotracheal tubes has been proven to be safe and efficacious, reducing the incidence of hypoxia and bradycardia episodes associated to surfactant administration.<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">29</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Prophylaxis versus rescue</span><p id="par0165" class="elsevierStylePara elsevierViewall">Several clinical trials have tried to establish the optimal timing of surfactant administration during the course of RDS. One meta-analysis of all these studies published by the Cochrane Review in 2001 reported that early administration of surfactant therapy either as prophylaxis (<30<span class="elsevierStyleHsp" style=""></span>min of life) or as early rescue treatment (<2<span class="elsevierStyleHsp" style=""></span>h of life in symptomatic patients) has been proven to decrease the risk of pneumothorax, death, and the combined outcome of death and bronchopulmonary dysplasia. The most significant results were found in the cohort of preterm infants less than<span class="elsevierStyleHsp" style=""></span>30 weeks of gestation that required invasive ventilatory support at birth.<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">30</span></a></p><p id="par0170" class="elsevierStylePara elsevierViewall">However, nowadays, with the increased prenatal administration of corticosteroids and the widespread use of CPAP in the delivery room, many preterm newborns can be treated without resorting to endotracheal intubation unless there is clinical evidence of RDS. There are probably no noticeable differences in clinical outcomes between prophylactic administration and very early rescue surfactant in the first 30<span class="elsevierStyleHsp" style=""></span>min of life, so intubation may be delayed until it is clearly needed. Based on the recently published literature, we can state that initial stabilisation with CPAP and administration of rescue surfactant if needed is as safe and efficacious as intubation, mechanical ventilation and surfactant administration immediately after birth in this group of patients as it concerns their clinical outcomes, and thus we join the recommendations established in Scandinavian countries.<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">31,32</span></a></p><p id="par0175" class="elsevierStylePara elsevierViewall">The decision of which approach to use in early respiratory management may be based on the identification of the risk population labelled extremely preterm newborns (without a specific overall definition of the cut-off gestational age) that have not been treated with antenatal corticosteroids.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Adverse effects</span><p id="par0180" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">-</span><p id="par0185" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Airway obstruction:</span> occurs more frequently with higher-volume preparations, and can cause desaturation and/or bradycardia. Sometimes, part of the surfactant can be seen flowing back up the endotracheal tube.</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">-</span><p id="par0190" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Changes in cerebral blood flow:</span> the administration of surfactant in the context of respiratory distress produces an increase in the mean blood flow velocity in the middle cerebral artery that is sustained for up to 45<span class="elsevierStyleHsp" style=""></span>min following administration. Slow instillation of smaller volumes has been suggested as a possible strategy to minimise these haemodynamic changes.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">9</span></a></p></li></ul></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Recommendations</span><p id="par0195" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">1.</span><p id="par0200" class="elsevierStylePara elsevierViewall">The administration of surfactant is safe and efficacious for the first-line treatment of RDS in preterm newborns (A).</p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">2.</span><p id="par0205" class="elsevierStylePara elsevierViewall">It can be efficacious for the treatment of other acute respiratory pathologies (B).</p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">3.</span><p id="par0210" class="elsevierStylePara elsevierViewall">Early rescue treatment is the most adequate therapeutic approach (A).</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">4.</span><p id="par0215" class="elsevierStylePara elsevierViewall">Double-lumen endotracheal tubes and noninvasive techniques are safe and effective means of administration (B).</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">5.</span><p id="par0220" class="elsevierStylePara elsevierViewall">The most appropriate regimen consists of an initial dose of 100–200<span class="elsevierStyleHsp" style=""></span>mg/kg (depending on the type of surfactant), with a maximum of three doses depending on the clinical response of the patient (A).</p></li></ul></p></span></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Inhaled nitric oxide</span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Rationale</span><p id="par0225" class="elsevierStylePara elsevierViewall">Nitric oxide (NO) is a small gaseous molecule that is mainly produced by the alveolar and vascular endothelium from the amino acid <span class="elsevierStyleSmallCaps">l</span>-arginine by the action of NO synthase. At the cellular level, it stimulates guanylate cyclase to increase intracellular cGMP, which has a powerful vasodilatory effect on smooth muscle tissue, promoting tissue perfusion wherever it is released.</p><p id="par0230" class="elsevierStylePara elsevierViewall">Synthetic NO is manufactured for commercialization in gaseous form, and can be administered by inhalation (iNO) so that it diffuses quickly to smooth muscle tissues after reaching the alveoli, producing selective vasodilation of the pulmonary region and improving the ventilation/perfusion ratio wherever it is absorbed.</p><p id="par0235" class="elsevierStylePara elsevierViewall">Its half-life ranges between 3 and 4<span class="elsevierStyleHsp" style=""></span>s, as it is rapidly inactivated in the bloodstream, giving rise to methaemoglobin (MetHb). For this reason, its effects do not extend beyond the area where it is absorbed.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">33</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Therapeutic indications</span><p id="par0240" class="elsevierStylePara elsevierViewall">The main therapeutic indication of iNO is pulmonary hypertension (PHT), be it primary or secondary to pulmonary pathologies (neonatal RDS, MAS, congenital diaphragmatic hernia, pneumonia) or associated with congenital heart diseases (both pre and post surgery).</p><p id="par0245" class="elsevierStylePara elsevierViewall">Clinical trials conducted in late preterm (>34 weeks) or full-term newborns have observed that iNO improves oxygenation indices and reduces the need for ECMO and the incidence of bronchopulmonary dysplasia. However, it does not influence mortality, and the worst outcomes are found in newborns with diaphragmatic hernia.<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">34,35</span></a></p><p id="par0250" class="elsevierStylePara elsevierViewall">The results of published studies on the use of iNO in preterm newborns suggest that it can improve oxygenation but that it does not improve survival rates.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">36</span></a></p><p id="par0255" class="elsevierStylePara elsevierViewall">On the other hand, the early use of low-dose iNO in preterm newborns does not improve the rate of survival without development of bronchopulmonary dysplasia or brain damage, so it is not a satisfactory preventive strategy.<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">37</span></a></p><p id="par0260" class="elsevierStylePara elsevierViewall">Thus, treatment with iNO will be considered in patients with severe hypoxaemic respiratory failure and evidence of PHT (difference between pre- and postductal SpO<span class="elsevierStyleInf">2</span> >5%, echocardiographic evidence) when they have an oxygenation index (OI) above 25 in two successive measurements at least 30<span class="elsevierStyleHsp" style=""></span>min apart (IO<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>MAP<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100/postductal PaO<span class="elsevierStyleInf">2</span>). Some authors indicate that early initiation of treatment with iNO with OIs between 10 and 20 offers clinical benefits, reducing the amount of oxygen therapy and the need for ECMO.<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">38</span></a></p><p id="par0265" class="elsevierStylePara elsevierViewall">We cannot recommend the routine use of iNO for the treatment of respiratory failure in preterm newborns, and it will only be considered in cases of severe hypoxaemia as a rescue therapy, following optimisation of lung recruitment, and delivered in low doses (<10<span class="elsevierStyleHsp" style=""></span>ppm).</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Practical management</span><p id="par0270" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">1.</span><p id="par0275" class="elsevierStylePara elsevierViewall">Since iNO diffuses through the alveolar endothelium, it requires effective lung recruitment prior to its initiation. High-frequency ventilation can be used to achieve this when needed.</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">2.</span><p id="par0280" class="elsevierStylePara elsevierViewall">Previous optimisation of all factors that promote pulmonary vasoconstriction: optimisation of oxygenation, maintenance of a pH ≥7.40 with normocapnia (pCO<span class="elsevierStyleInf">2</span>, 45–40<span class="elsevierStyleHsp" style=""></span>mmHg), sedoanalgesia, normothermia, haemodynamic management, electrolyte normalisation (especially glucose and calcium) and correction of anaemia.</p></li><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">3.</span><p id="par0285" class="elsevierStylePara elsevierViewall">According to the Food and Drug Administration, iNO must be delivered using an appropriate system with a gas injector module capable of maintaining the concentration of iNO constant during the inspiratory flow. Furthermore, the time that iNO mixes with oxygen should be minimised to avoid the formation of potentially toxic gases, and the device should include a monitoring system, with alarms, for administered NO and O<span class="elsevierStyleInf">2</span> and generated NO<span class="elsevierStyleInf">2</span>.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">36</span></a></p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">4.</span><p id="par0290" class="elsevierStylePara elsevierViewall">Initiate iNO with 10–20<span class="elsevierStyleHsp" style=""></span>ppm (5<span class="elsevierStyleHsp" style=""></span>ppm in preterm newborns). Patients usually respond quickly, within the first 60<span class="elsevierStyleHsp" style=""></span>min (OI<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>10, F<span class="elsevierStyleInf">i</span>O<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>70). A patient is considered to show a poor response if the postductal PaO<span class="elsevierStyleInf">2</span> does not increase by 20% within 60–90<span class="elsevierStyleHsp" style=""></span>min, in which case higher doses may be tried of up to 40<span class="elsevierStyleHsp" style=""></span>ppm (10<span class="elsevierStyleHsp" style=""></span>ppm in preterm newborns), although improvement will rarely follow. Up to 40% of patients do not respond to iNO.</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">5.</span><p id="par0295" class="elsevierStylePara elsevierViewall">MetHb monitoring every 24<span class="elsevierStyleHsp" style=""></span>h.</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">6.</span><p id="par0300" class="elsevierStylePara elsevierViewall">In patients that do not respond, iNO will be weaned in a progressive and slow manner (halving the dose every 10–15<span class="elsevierStyleHsp" style=""></span>min to its discontinuation). In responsive patients, the dose of supplemental oxygen will be tapered down to 0.6 first, and then the dose of iNO will be reduced slowly until reaching the minimum effective dose. If oxygenation worsens as the dose is reduced (requirement increase >15% of previous requirement), the dose will be increased back to the previous amount and will be maintained for several hours before attempting weaning again.</p></li></ul></p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Side effects</span><p id="par0305" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">-</span><p id="par0310" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Methaemoglobinaemia</span>: results from the reaction of NO with haemoglobin, so that the latter cannot transport oxygen. It is recommended that the levels of methaemoglobin (MetHb) are monitored in all patients requiring treatment with iNO; the dose of iNO must be reduced when MetHb ranges between 2.5% and 5% (if the condition of the patient allows it) and iNO suspended when the level exceeds 5%. Preterm newborns are at higher risk of MetHb toxicity because they have lower levels of MetHb reductase.</p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">-</span><p id="par0315" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Increased nitrogen dioxide</span> (NO<span class="elsevierStyleInf">2</span>) <span class="elsevierStyleItalic">concentration</span>: this results from the reaction of NO with high oxygen concentrations in the circuit and airway. Levels above 3<span class="elsevierStyleHsp" style=""></span>ppm can cause pulmonary damage, oedema and oxidative stress resulting from the production of peroxynitrite. However, this is an infrequent occurrence at the recommended doses.</p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">-</span><p id="par0320" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Inhibition of platelet aggregation:</span> it can increase the risk of haemorrhage.</p></li></ul></p></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conflicts of interest</span><p id="par0325" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:3 [ "identificador" => "xres585608" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec601470" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres585609" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec601469" "titulo" => "Palabras clave" ] 4 => array:3 [ "identificador" => "sec0005" "titulo" => "Surfactant" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0010" "titulo" => "General concepts and types of surfactants" "secciones" => array:6 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Indications" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Administration and dosage" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Methods of administration" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Prophylaxis versus rescue" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Adverse effects" ] 5 => array:2 [ "identificador" => "sec0040" "titulo" => "Recommendations" ] ] ] ] ] 5 => array:3 [ "identificador" => "sec0045" "titulo" => "Inhaled nitric oxide" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0050" "titulo" => "Rationale" ] 1 => array:2 [ "identificador" => "sec0055" "titulo" => "Therapeutic indications" ] 2 => array:2 [ "identificador" => "sec0060" "titulo" => "Practical management" ] 3 => array:2 [ "identificador" => "sec0065" "titulo" => "Side effects" ] ] ] 6 => array:2 [ "identificador" => "sec0070" "titulo" => "Conflicts of interest" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-01-12" "fechaAceptado" => "2015-02-18" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec601470" "palabras" => array:5 [ 0 => "Respiratory support" 1 => "Surfactant" 2 => "Inhaled nitric oxide" 3 => "Evidence based practice" 4 => "Newborn" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec601469" "palabras" => array:5 [ 0 => "Asistencia respiratoria" 1 => "Surfactante" 2 => "Óxido nítrico inhalado" 3 => "Práctica basada en la evidencia" 4 => "Recién nacido" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The recommendations included in this document will be part of a series of updated reviews of the literature on respiratory support in the newborn infant. These recommendations are structured into twelve modules, and in this work module 7 is presented. Each module is the result of a consensus process including all members of the Surfactant and Respiratory Group of the Spanish Society of Neonatology. They represent a summary of the published papers on each specific topic, and of the clinical experience of each one of the members of the group.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Las recomendaciones incluidas en este documento forman parte de una revisión actualizada de la asistencia respiratoria en el recién nacido. Están estructuradas en 12 módulos y en este trabajo se presenta el módulo 7. El contenido de cada módulo es el resultado del consenso de los miembros del Grupo Respiratorio y Surfactante de la Sociedad Española de Neonatología. Representan una síntesis de los trabajos publicados y de la experiencia clínica de cada uno de los miembros del grupo.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Castillo Salinas F, Elorza Fernández D, Gutiérrez Laso A, Moreno Hernando J, Bustos Lozano G, Gresa Muñoz M, et al. Recomendaciones para la asistencia respiratoria en el recién nacido (<span class="elsevierStyleSmallCaps">iii</span>). Surfactante y óxido nítrico. An Pediatr (Barc). 2015;83:354.e1–354.e6.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Type \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Surfactant \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Recommended dose \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Volume \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Natural \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Beractant (Survanta<span class="elsevierStyleSup">®</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4<span class="elsevierStyleHsp" style=""></span>mL/kg \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Calfactant (Infasurf<span class="elsevierStyleSup">®</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">105<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3<span class="elsevierStyleHsp" style=""></span>mL/kg \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Poractant (Curosurf<span class="elsevierStyleSup">®</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">200<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.5<span class="elsevierStyleHsp" style=""></span>mL/kg \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Synthetic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Lucinactant (Surfaxin<span class="elsevierStyleSup">®</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">175<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.8<span class="elsevierStyleHsp" style=""></span>mL/kg \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab955944.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Dosage of the different surfactant types.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:38 [ 0 => array:3 [ "identificador" => "bib0195" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The importance of surfactant on the development of neonatal pulmonary disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Pinheiro" 1 => "E. Alburquerque" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2007" "volumen" => "62" "paginaInicial" => "181" "paginaFinal" => "190" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17505704" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0200" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactant replacement therapy for respiratory distress in the preterm and term neonate" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "American Academy of Pediatrics Committee on Fetus and Newborn" "etal" => false "autores" => array:1 [ 0 => "W.A. Engle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3171/2013.5.PEDS13200" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2008" "volumen" => "12" "paginaInicial" => "419" "paginaFinal" => "432" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23992234" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0205" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European Consensus Guidelines on the management of neonatal respiratory distress syndrome in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Sweet" 1 => "V. Carnielli" 2 => "G. Greisen" 3 => "N. Hallman" 4 => "E. Ozeck" 5 => "R. Plavka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000297773" "Revista" => array:6 [ "tituloSerie" => "Neonatology" "fecha" => "2010" "volumen" => "97" "paginaInicial" => "402" "paginaFinal" => "417" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20551710" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0210" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myth: all surfactants are alike" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Moya" 1 => "M.C. Javier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.siny.2011.03.006" "Revista" => array:6 [ "tituloSerie" => "Semin Fetal Neonatal Med" "fecha" => "2011" "volumen" => "16" "paginaInicial" => "269" "paginaFinal" => "274" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21515101" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0215" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.F. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD000144" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2001" "volumen" => "2" "paginaInicial" => "CD000144" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11405951" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0220" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Synthetic surfactants: the search goes on" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. Kattwinkel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2005-0202" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2005" "volumen" => "115" "paginaInicial" => "1075" "paginaFinal" => "1076" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15805389" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0225" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multicenter, randomized, masked, comparison trial of lucinactan, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Moya" 1 => "E. Bancalari" 2 => "J. Gadzinowaki" 3 => "V. Salinas" 4 => "B. Kopelman" 5 => "A. Bancalari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2004-2183" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2005" "volumen" => "115" "paginaInicial" => "1018" "paginaFinal" => "1029" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15805380" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0230" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multicenter, randomized, masked, comparison trial of lucinactan versus poractant alfa among very premature infants at high risk for respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.K. Sinha" 1 => "T. Lacaze" 2 => "A. Valls" 3 => "T. Wiswell" 4 => "J. Gadzinowski" 5 => "J. Hajdu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2004-2231" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2005" "volumen" => "115" "paginaInicial" => "1030" "paginaFinal" => "1038" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15805381" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0235" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactants: past, present and future" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.L. Halliday" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jp.2008.50" "Revista" => array:6 [ "tituloSerie" => "J Perinatol" "fecha" => "2008" "volumen" => "28" "paginaInicial" => "s47" "paginaFinal" => "s56" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18446178" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0240" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of infasurf and survanta in the prevention and treatment of respiratory distress syndrome" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Infasurf Survanta Clinical Trial Group" "etal" => false "autores" => array:2 [ 0 => "B.T. Bloom" 1 => "R.H. Clark" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2004-2783" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2005" "volumen" => "116" "paginaInicial" => "392" "paginaFinal" => "399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16061594" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0245" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.E. Cogo" 1 => "M. Facco" 2 => "M. Simonato" 3 => "G. Verlato" 4 => "C. Rondina" 5 => "A. Baritussio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2009-0126" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2009" "volumen" => "124" "paginaInicial" => "e950" "paginaFinal" => "e957" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19822594" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0250" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Animal derived surfactant extract for treatment of respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "N. Seger" 1 => "R. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD007836" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2009" "volumen" => "2" "paginaInicial" => "CD007836" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19370695" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0255" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current trials in the treatment of respiratory failure in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.F. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000209303" "Revista" => array:6 [ "tituloSerie" => "Neonatology" "fecha" => "2009" "volumen" => "95" "paginaInicial" => "368" "paginaFinal" => "372" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19494559" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0260" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Synthetic surfactant for respiratory distress syndrome in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.F. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2000" "paginaInicial" => "CD0001149" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0265" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.F. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2000" "paginaInicial" => "CD0000511" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0270" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactant for meconium aspiration syndrome in full term/near term infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A.I. El Shahed" 1 => "P. Dargaville" 2 => "A. Ohlsson" 3 => "R.F. Soll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD002054.pub2" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2007" "volumen" => "3" "paginaInicial" => "CD002054" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17636695" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0275" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactant therapy for meconium aspiration syndrome. Current status" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Dargaville" 1 => "J. Mills" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2005" "volumen" => "65" "paginaInicial" => "2569" "paginaFinal" => "2591" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16392874" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0280" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Innovation in surfactant therapy: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Dargaville" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000337346" "Revista" => array:6 [ "tituloSerie" => "Neonatology" "fecha" => "2012" "volumen" => "101" "paginaInicial" => "326" "paginaFinal" => "336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22940622" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0285" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "T. Amizuka" 1 => "H. Shimizu" 2 => "Y. Niida" 3 => "Y. Ogawa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00431-003-1276-x" "Revista" => array:6 [ "tituloSerie" => "Eur J Pediatr" "fecha" => "2003" "volumen" => "162" "paginaInicial" => "697" "paginaFinal" => "702" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12898240" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0290" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary surfactants for neonatal respiratory disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Merril" 1 => "R. Ballard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Opin Pediatr" "fecha" => "2003" "volumen" => "15" "paginaInicial" => "149" "paginaFinal" => "154" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12640270" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0295" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Lotze" 1 => "B. Mitchell" 2 => "D. Bulas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Pediatr" "fecha" => "1998" "volumen" => "132" "paginaInicial" => "40" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9469998" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0300" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surfactant administration by transient intubation in infants 29 to 35 weeks’ gestation with respiratory distress syndrome decrease the likelihood of later mechanical ventilation: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Reininger" 1 => "R. Khalal" 2 => "J. Kendig" 3 => "R. Ryan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Perinat" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "703" "paginaFinal" => "708" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0305" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An open label, pilot study of Aerosurf combined with nCPAP to prevent RDS in preterm neonates" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N.N. Finer" 1 => "T.A. Merrit" 2 => "G. Berstein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/jamp.2009.0758" "Revista" => array:6 [ "tituloSerie" => "J Aerosol Med Pulm Drug Deliv" "fecha" => "2010" "volumen" => "23" "paginaInicial" => "303" "paginaFinal" => "309" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20455772" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0310" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preliminary evaluation of a new technique of minimally invasive surfactant therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.A. Dargaville" 1 => "A. Aiyappan" 2 => "A. Cornelius" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Dis Child Fetal Neonatal Ed" "fecha" => "2011" "volumen" => "4" "paginaInicial" => "f243" "paginaFinal" => "f248" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0315" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Trevisanuto" 1 => "N. Grazzina" 2 => "P. Ferrarese" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000083370" "Revista" => array:6 [ "tituloSerie" => "Biol Neonate" "fecha" => "2005" "volumen" => "87" "paginaInicial" => "217" "paginaFinal" => "220" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15650304" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0320" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2013 update" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Sweet" 1 => "V. Carnielli" 2 => "G. Greisen" 3 => "M. Hallman" 4 => "E. Ozek" 5 => "R. Plavka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000349928" "Revista" => array:6 [ "tituloSerie" => "Neonatology" "fecha" => "2013" "volumen" => "103" "paginaInicial" => "353" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23736015" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0325" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Soll" 1 => "O. Eren" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2009" "paginaInicial" => "CD000141" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0330" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Practical issues in surfactant replace therapy in respiratory distress syndrome in newborns" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Upadhyay" 1 => "P. Lal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Neonatol" "fecha" => "2011" "volumen" => "25" "paginaInicial" => "91" "paginaFinal" => "97" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0335" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Valls-i-Soler" 1 => "B. Fernández-Ruanova" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediatrics" "fecha" => "1998" "volumen" => "101" "paginaInicial" => "e4" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9606246" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0340" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prophylactic vs. selective use of surfactant in preventing morbidity and mortality in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Soll" 1 => "C. Morley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2001" "paginaInicial" => "CD000510" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0345" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nasal CPAP or intubation at birth for very preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "C.J. Morley" 1 => "P.G. Davis" 2 => "L.W. Doyle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa072788" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "358" "paginaInicial" => "700" "paginaFinal" => "708" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18272893" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0350" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prophylactic or early selective surfactant combined with nCPAP in very preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F. Sandri" 1 => "R. Plavka" 2 => "G. Ancora" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2009-2131" "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "2010" "volumen" => "125" "paginaInicial" => "e1402" "paginaFinal" => "e1409" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20439601" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0355" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recomendaciones para la utilización de óxido nítrico inhalado en patología neonatal" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Grupo Respiratorio Neonatal de la SEN" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "An Esp Pediatr" "fecha" => "2001" "volumen" => "55" "paginaInicial" => "251" "paginaFinal" => "255" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11676901" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0360" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The management of neonatal pulmonary hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Dhillon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/adc.2009.180091" "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child Fetal Neonatal Ed" "fecha" => "2012" "volumen" => "97" "paginaInicial" => "f223" "paginaFinal" => "f228" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21278430" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0365" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence-based clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Di Blasi" 1 => "T. Myers" 2 => "D. Hess" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Respir Care" "fecha" => "2010" "volumen" => "55" "paginaInicial" => "1717" "paginaFinal" => "1745" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21122181" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0370" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled nitric oxide for respiratory failure in preterm infants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K.J. Barrington" 1 => "N. Finer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD000509.pub4" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2010" "volumen" => "12" "paginaInicial" => "CD000509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21154346" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0375" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:4 [ 0 => "J.C. Mercier" 1 => "H. Hummler" 2 => "X. Durrmeyer" 3 => "M. Sanchez Luna" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet" "fecha" => "2010" "volumen" => "31" "paginaInicial" => "346" "paginaFinal" => "354" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0380" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recomendaciones para la utilización de óxido nítrico inhalado en patología neonata" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Comisión de estándares de la SEN" "etal" => false "autores" => array:3 [ 0 => "J. Figueras" 1 => "F. Castillo" 2 => "D. Elorza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr (Barc)" "fecha" => "2006" "volumen" => "64" "paginaInicial" => "260" "paginaFinal" => "266" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:3 [ "titulo" => "Acknowledgments" "texto" => "<p id="par0330" class="elsevierStylePara elsevierViewall">We want to thank Professor Adolf Valls, who will always remain in our memories.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000008300000005/v1_201512040119/S2341287915001775/v1_201512040119/en/main.assets" "Apartado" => array:4 [ "identificador" => "33443" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Spanish Association of Paediatrics" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000008300000005/v1_201512040119/S2341287915001775/v1_201512040119/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287915001775?idApp=UINPBA00005H" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 7 | 4 | 11 |
2024 October | 57 | 62 | 119 |
2024 September | 69 | 46 | 115 |
2024 August | 91 | 81 | 172 |
2024 July | 49 | 41 | 90 |
2024 June | 73 | 44 | 117 |
2024 May | 66 | 45 | 111 |
2024 April | 64 | 43 | 107 |
2024 March | 57 | 35 | 92 |
2024 February | 44 | 34 | 78 |
2024 January | 41 | 39 | 80 |
2023 December | 38 | 17 | 55 |
2023 November | 37 | 54 | 91 |
2023 October | 58 | 45 | 103 |
2023 September | 28 | 32 | 60 |
2023 August | 46 | 24 | 70 |
2023 July | 43 | 36 | 79 |
2023 June | 36 | 31 | 67 |
2023 May | 53 | 37 | 90 |
2023 April | 40 | 18 | 58 |
2023 March | 66 | 33 | 99 |
2023 February | 57 | 21 | 78 |
2023 January | 34 | 20 | 54 |
2022 December | 67 | 33 | 100 |
2022 November | 75 | 59 | 134 |
2022 October | 59 | 64 | 123 |
2022 September | 50 | 33 | 83 |
2022 August | 50 | 70 | 120 |
2022 July | 53 | 47 | 100 |
2022 June | 41 | 46 | 87 |
2022 May | 39 | 59 | 98 |
2022 April | 38 | 52 | 90 |
2022 March | 80 | 53 | 133 |
2022 February | 48 | 34 | 82 |
2022 January | 60 | 37 | 97 |
2021 December | 57 | 43 | 100 |
2021 November | 68 | 63 | 131 |
2021 October | 62 | 71 | 133 |
2021 September | 55 | 40 | 95 |
2021 August | 51 | 71 | 122 |
2021 July | 40 | 33 | 73 |
2021 June | 35 | 42 | 77 |
2021 May | 68 | 39 | 107 |
2021 April | 187 | 54 | 241 |
2021 March | 128 | 47 | 175 |
2021 February | 74 | 18 | 92 |
2021 January | 80 | 17 | 97 |
2020 December | 73 | 25 | 98 |
2020 November | 78 | 15 | 93 |
2020 October | 65 | 16 | 81 |
2020 September | 80 | 37 | 117 |
2020 August | 65 | 20 | 85 |
2020 July | 53 | 25 | 78 |
2020 June | 64 | 11 | 75 |
2020 May | 63 | 25 | 88 |
2020 April | 54 | 21 | 75 |
2020 March | 48 | 33 | 81 |
2020 February | 45 | 3 | 48 |
2020 January | 55 | 20 | 75 |
2019 December | 82 | 22 | 104 |
2019 November | 64 | 17 | 81 |
2019 October | 72 | 23 | 95 |
2019 September | 49 | 16 | 65 |
2019 August | 89 | 21 | 110 |
2019 July | 49 | 22 | 71 |
2019 June | 32 | 36 | 68 |
2019 May | 54 | 34 | 88 |
2019 April | 100 | 36 | 136 |
2019 March | 32 | 25 | 57 |
2019 February | 46 | 27 | 73 |
2019 January | 39 | 31 | 70 |
2018 December | 51 | 32 | 83 |
2018 November | 199 | 29 | 228 |
2018 October | 360 | 16 | 376 |
2018 September | 125 | 25 | 150 |
2018 August | 1 | 0 | 1 |
2018 July | 1 | 0 | 1 |
2018 June | 2 | 0 | 2 |
2018 May | 15 | 0 | 15 |
2018 April | 52 | 0 | 52 |
2018 March | 147 | 0 | 147 |
2018 February | 13 | 0 | 13 |
2018 January | 14 | 0 | 14 |
2017 December | 11 | 0 | 11 |
2017 November | 24 | 0 | 24 |
2017 October | 25 | 0 | 25 |
2017 September | 23 | 0 | 23 |
2017 August | 25 | 0 | 25 |
2017 July | 22 | 1 | 23 |
2017 June | 27 | 8 | 35 |
2017 May | 26 | 13 | 39 |
2017 April | 24 | 13 | 37 |
2017 March | 16 | 2 | 18 |
2017 February | 8 | 8 | 16 |
2017 January | 8 | 7 | 15 |
2016 December | 17 | 3 | 20 |
2016 November | 18 | 5 | 23 |
2016 October | 32 | 12 | 44 |
2016 September | 33 | 1 | 34 |
2016 August | 31 | 7 | 38 |
2016 July | 15 | 2 | 17 |